In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines
Neuroblastoma is the most frequent malignant extracranial solid tumor of infancy. The overall objective of this work consists of determining the presence of alterations in the p53/MDM2/p14ARF signaling pathway in neuroblastoma cell lines and deciphering their possible relationship with resistance to...
Guardado en:
Autores principales: | Idoia Blanco-Luquin, Paula Lázcoz, Jon Celay, Javier S. Castresana, Ignacio J. Encío |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6950787a05a7476b91ba394d33fd172f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
p53-Mediated Radiosensitization of <sup>177</sup>Lu-DOTATATE in Neuroblastoma Tumor Spheroids
por: Sara Lundsten, et al.
Publicado: (2021) -
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
por: Danrui Cui, et al.
Publicado: (2021) -
Hemorrhage During Induction Chemotherapy in Neuroblastoma: Additional Risk Factors in High-Risk Patients
por: Valerio Voglino, et al.
Publicado: (2021) -
Olfactory neuroblastoma managed with endoscopic sinus surgery
por: Saleh Mayoof Al-Osaimi, et al.
Publicado: (2021) -
Neuroblastomas en el niño
por: E,BAUZA, et al.
Publicado: (1950)